PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,098 | +53.3% | 5,761 | 0.0% | 0.00% | – |
| Q4 2022 | $7,893 | +31.6% | 5,761 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 5,761 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 5,761 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 5,761 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -37.5% | 5,761 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -27.3% | 5,761 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -57.7% | 5,761 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +23.8% | 5,761 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | -4.5% | 5,761 | 0.0% | 0.00% | – |
| Q3 2020 | $22,000 | 0.0% | 5,761 | 0.0% | 0.00% | – |
| Q2 2020 | $22,000 | +57.1% | 5,761 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | -26.3% | 5,761 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | – | 5,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
| CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
| IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |